Dr Sara M. Tolaney reviews the currently available treatment options for HER2-positive metastatic breast cancer and notes that many new HER2-targeting ...

Treatment for HER2-negative metastatic breast cancer depends on factors like hormone receptor status, with chemo/immunotherapy for PD-L1-positive triple ...

A discusses the FDA’s investigation into the possible association between CAR-T cell therapy and secondary T-cell malignancies.

Treatment for HER2 low metastatic breast cancer may utilize HER2-targeted antibody-drug conjugates like T-DM1 and sacituzumab govitecan after initial ...

HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular ...

Imaging scans provide an invaluable method of monitoring response to HER2-positive breast cancer treatment; frequency of imaging scans depends on individual ...

Patients on HER2-targeted therapies for HER2-positive metastatic breast cancer should be vigilant about potential side effects like heart toxicities and ...

Patients with metastatic breast cancer receiving HER2-targeted therapies should promptly report any respiratory symptoms or signs of lung and heart disease ...

While analysis of molecular subtypes of muscle-invasive bladder cancer using tumor RNA expression can improve the ability to predict the likelihood of ...

Patient-facing artificial intelligence (AI) has been used more in recent years; however, it may cause some ethical challenges and threats to a patient’s ...

Christine Cooper, RN, BSN, provides a preview of an upcoming CURE Expert Connections program discussing advancements in the care of myelofibrosis, including ...

Living through a war in real time has affected my life. I recently went for my three-month check-up with my oncologist and for the first time, my blood ...